XML 31 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - UNAUDITED - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Earnings
Balance, beginning of period at Dec. 31, 2019 $ 396,662 $ 696 $ 454,663 $ (867,817) $ (39,503) $ 848,623
Balance, beginning of period, shares at Dec. 31, 2019   32,891        
Net income           21,514
Unrealized gain (loss) on short-term investments, net of tax         (24)  
Foreign currency translation adjustments         (15,084)  
Total comprehensive income, net of tax 6,406          
Repurchase of common stock (13,965) $ (2) (7,555) (6,408)    
Repurchase of common stock, shares   (299)        
Issuance of common stock pursuant to employee stock purchase plan 564   564      
Issuance of common stock pursuant to employee stock purchase plan, shares   14        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 5 (5)      
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   476        
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (7)        
Stock-based compensation expense 4,857   4,857      
Dividends (7,693)         (7,693)
Balance, ending of period at Mar. 31, 2020 386,831 $ 699 452,524 (874,225) (54,611) 862,444
Balance, ending of period, shares at Mar. 31, 2020   33,075        
Balance, beginning of period at Dec. 31, 2019 396,662 $ 696 454,663 (867,817) (39,503) 848,623
Balance, beginning of period, shares at Dec. 31, 2019   32,891        
Net income 31,880          
Unrealized gain (loss) on short-term investments, net of tax 28          
Foreign currency translation adjustments (12,413)          
Total comprehensive income, net of tax 19,495          
Balance, ending of period at Jun. 30, 2020 397,622 $ 699 458,362 (874,592) (51,888) 865,041
Balance, ending of period, shares at Jun. 30, 2020   33,080        
Balance, beginning of period at Mar. 31, 2020 386,831 $ 699 452,524 (874,225) (54,611) 862,444
Balance, beginning of period, shares at Mar. 31, 2020   33,075        
Net income 10,366         10,366
Unrealized gain (loss) on short-term investments, net of tax 52       52  
Foreign currency translation adjustments 2,671       2,671  
Total comprehensive income, net of tax 13,089          
Repurchase of common stock (467)   (100) (367)    
Repurchase of common stock, shares   (11)        
Issuance of common stock pursuant to employee stock purchase plan 683   683      
Issuance of common stock pursuant to employee stock purchase plan, shares   18        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   12        
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (14)        
Stock-based compensation expense 5,255   5,255      
Dividends (7,769)         (7,769)
Balance, ending of period at Jun. 30, 2020 397,622 $ 699 458,362 (874,592) (51,888) 865,041
Balance, ending of period, shares at Jun. 30, 2020   33,080        
Balance, beginning of period at Dec. 31, 2020 $ 422,395 $ 700 470,557 (894,126) (31,138) 876,402
Balance, beginning of period, shares at Dec. 31, 2020 32,713 32,713        
Net income           19,631
Unrealized gain (loss) on short-term investments, net of tax         (6)  
Foreign currency translation adjustments         (355)  
Total comprehensive income, net of tax $ 19,270          
Repurchase of common stock (11,721) $ (1) (5,202) (6,518)    
Repurchase of common stock, shares   (252)        
Issuance of common stock pursuant to employee stock purchase plan 619   619      
Issuance of common stock pursuant to employee stock purchase plan, shares   16        
Issuance of restricted common stock pursuant to stock-based compensation plans   $ 5 (5)      
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   487        
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (1)        
Stock-based compensation expense 5,395   5,395      
Dividends (8,243)         (8,243)
Balance, ending of period at Mar. 31, 2021 427,715 $ 704 471,364 (900,644) (31,499) 887,790
Balance, ending of period, shares at Mar. 31, 2021   32,963        
Balance, beginning of period at Dec. 31, 2020 $ 422,395 $ 700 470,557 (894,126) (31,138) 876,402
Balance, beginning of period, shares at Dec. 31, 2020 32,713 32,713        
Net income $ 38,952          
Unrealized gain (loss) on short-term investments, net of tax (13)          
Foreign currency translation adjustments 1,857          
Total comprehensive income, net of tax 40,796          
Balance, ending of period at Jun. 30, 2021 $ 439,780 $ 704 477,010 (907,601) (29,294) 898,961
Balance, ending of period, shares at Jun. 30, 2021 32,797 32,797        
Balance, beginning of period at Mar. 31, 2021 $ 427,715 $ 704 471,364 (900,644) (31,499) 887,790
Balance, beginning of period, shares at Mar. 31, 2021   32,963        
Net income 19,321         19,321
Unrealized gain (loss) on short-term investments, net of tax (7)       (7)  
Foreign currency translation adjustments 2,212       2,212  
Total comprehensive income, net of tax 21,526          
Repurchase of common stock (7,049)   (92) (6,957)    
Repurchase of common stock, shares   (156)        
Issuance of common stock pursuant to employee stock purchase plan 716   716      
Issuance of common stock pursuant to employee stock purchase plan, shares   19        
Issuance of restricted common stock pursuant to stock-based compensation plans, shares   6        
Cancellation of restricted common stock issued pursuant to stock-based compensation plans, shares   (35)        
Stock-based compensation expense 5,022   5,022      
Dividends (8,150)         (8,150)
Balance, ending of period at Jun. 30, 2021 $ 439,780 $ 704 $ 477,010 $ (907,601) $ (29,294) $ 898,961
Balance, ending of period, shares at Jun. 30, 2021 32,797 32,797